120 related articles for article (PubMed ID: 38219902)
1. Safety and Technical Feasibility of Percutaneous Renal Cryoablation of Central Tumors without Pyeloperfusion.
Pigg RA; Raja JY; Babar T; Li Y; Li M; Huang J; Gunn AJ
J Vasc Interv Radiol; 2024 Apr; 35(4):533-540. PubMed ID: 38219902
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success.
Raja J; Pigg R; Li Y; Savage C; Caridi TM; Huang J; Gunn AJ
Abdom Radiol (NY); 2024 Mar; 49(3):919-926. PubMed ID: 38150142
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation.
Marion JT; Schmitz JJ; Schmit GD; Kurup AN; Welch BT; Pasternak JJ; Boorjian SA; Leibovich BC; Atwell TD; Thompson RH
J Vasc Interv Radiol; 2020 Aug; 31(8):1249-1255. PubMed ID: 32457011
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
5. Transarterial embolization of T1b and T2a renal cell carcinoma prior to percutaneous cryoablation: a retrospective comparative study.
Salei A; Raymond M; Savage C; Huang J; Caridi TM; Rais-Bahrami S; Gunn AJ
Abdom Radiol (NY); 2023 Feb; 48(2):773-779. PubMed ID: 36454278
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes.
Gunn AJ; Joe WB; Salei A; El Khudari H; Mahmoud KH; Bready E; Keasler EM; Patten PP; Gordetsky JB; Rais-Bahrami S; Abdel Aal AK
Cardiovasc Intervent Radiol; 2019 Jul; 42(7):970-978. PubMed ID: 31044292
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous image-guided cryoablation with temporary balloon occlusion of the renal artery for the treatment of central renal tumors.
Autrusseau PA; Boatta E; Cazzato RL; Auloge P; Mayer T; Weiss J; Koch G; Caudrelier J; De Marini P; Gangi A; Garnon J
Diagn Interv Imaging; 2022 Nov; 103(11):510-515. PubMed ID: 35934617
[TBL] [Abstract][Full Text] [Related]
8. Safety and Effectiveness of Transhepatic Access for Percutaneous Renal Mass Cryoablation: A Multicenter Cohort.
Graif A; Ryan WJ; El Khudari HM; Schmit GD; Gunn AJ
J Vasc Interv Radiol; 2022 Nov; 33(11):1384-1389. PubMed ID: 35970503
[TBL] [Abstract][Full Text] [Related]
9. Image-guided thermal ablation of central renal tumors with retrograde cold pyeloperfusion technique: a monocentric experience.
Mauri G; Rossi D; Bonomo G; Camisassi N; Della Vigna P; Maiettini D; Varano GM; Monfardini L; Mascagni L; Orsi F
Int J Hyperthermia; 2020; 37(1):660-667. PubMed ID: 32552069
[No Abstract] [Full Text] [Related]
10. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
[TBL] [Abstract][Full Text] [Related]
12. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma.
An TJ; Arellano RS
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):281-288. PubMed ID: 33078234
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous renal cryoablation: experience treating 115 tumors.
Atwell TD; Farrell MA; Leibovich BC; Callstrom MR; Chow GK; Blute ML; Charboneau JW
J Urol; 2008 Jun; 179(6):2136-40; discussion 2140-1. PubMed ID: 18423719
[TBL] [Abstract][Full Text] [Related]
16. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes.
Kim DK; Won JY; Park SY
Acta Radiol; 2019 Jun; 60(6):798-804. PubMed ID: 30149751
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
